Chunliang Cheng

发表

Efficacy of Intra-Arterial Plus Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: A Pooled Analysis

X. Zu, Jinhui Liu, D. Qiu, 2021, Frontiers in Pharmacology.

Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study

X. Zu, Minfeng Chen, Hai-ge Chen, 2022, Cell reports. Medicine.

A novel signature to predict the neoadjuvant chemotherapy response of bladder carcinoma: Results from a territory multicenter real-world study

X. Zu, Minfeng Chen, Jinhui Liu, 2022, Frontiers in Genetics.

RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma

X. Zu, Jinhui Liu, Tao Guo, 2021, Frontiers in Oncology.

Music therapy effect on anxiety reduction among patients with cancer: A meta-analysis

Yongxin Zhou, Chunliang Cheng, Lu Zang, 2023, Frontiers in Psychology.

ACER2 forms a cold tumor microenvironment and predicts the molecular subtype in bladder cancer: Results from real-world cohorts

Jinhui Liu, Yuanqing Dai, D. Deng, 2023, Frontiers in Genetics.

S100A5 Attenuates Efficiency of Anti‐PD‐L1/PD‐1 Immunotherapy by Inhibiting CD8+ T Cell‐Mediated Anti‐Cancer Immunity in Bladder Carcinoma

Minfeng Chen, Zhi Liu, M. Mo, 2023, Advanced science.

Re: Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, et al. Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer. Eur Urol. 2023;83:313-7.

Jinbo Chen, Chunliang Cheng, Jiao Hu, 2023, European urology.